These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33384958)

  • 1. Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient.
    Boldrini L; Romano A; Placidi L; Mattiucci GC; Chiloiro G; Cusumano D; Pollutri V; Antonelli MV; Indovina L; Gambacorta MA; Valentini V
    Front Oncol; 2020; 10():601739. PubMed ID: 33384958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.
    Cuccia F; Rigo M; Gurrera D; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Attinà G; Pastorello E; De Simone A; Naccarato S; Sicignano G; Ruggieri R; Alongi F
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3269-3277. PubMed ID: 34268583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis.
    Boldrini L; Romano A; Chiloiro G; Corradini S; De Luca V; Verusio V; D'Aviero A; Castelluccia A; Alitto AR; Catucci F; Grimaldi G; Trapp C; Hörner-Rieber J; Marchesano D; Frascino V; Mattiucci GC; Valentini V; Gentile P; Gambacorta MA
    Radiat Oncol; 2023 May; 18(1):84. PubMed ID: 37218005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations.
    Placidi L; Romano A; Chiloiro G; Cusumano D; Boldrini L; Cellini F; Mattiucci GC; Valentini V
    Tech Innov Patient Support Radiat Oncol; 2020 Sep; 15():15-21. PubMed ID: 32642565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
    Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
    Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery.
    Lagerwaard F; Bohoudi O; Tetar S; Admiraal MA; Rosario TS; Bruynzeel A
    Cureus; 2018 Apr; 10(4):e2434. PubMed ID: 29876156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
    Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.
    Sandoval ML; Youssef I; Latifi K; Grass GD; Torres-Roca J; Rosenberg S; Yamoah K; Johnstone PA
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
    Michalet M; Bettaïeb O; Khalfi S; Ghorbel A; Valdenaire S; Debuire P; Aillères N; Draghici R; De Méric De Bellefon M; Charissoux M; Boisselier P; Demontoy S; Marguerit A; Cabaillé M; Cantaloube M; Keskes A; Bouhafa T; Farcy-Jacquet MP; Fenoglietto P; Azria D; Riou O
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
    Henke LE; Olsen JR; Contreras JA; Curcuru A; DeWees TA; Green OL; Michalski J; Mutic S; Roach MC; Bradley JD; Parikh PJ; Kashani R; Robinson CG
    Adv Radiat Oncol; 2019; 4(1):201-209. PubMed ID: 30706029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
    Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
    Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy.
    Redler G; Stevens T; Cammin J; Malin M; Green O; Mutic S; Pitroda S; Aydogan B
    Cureus; 2019 Dec; 11(12):e6364. PubMed ID: 31938646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.
    Tetar SU; Bruynzeel AME; Lagerwaard FJ; Slotman BJ; Bohoudi O; Palacios MA
    Phys Imaging Radiat Oncol; 2019 Jan; 9():69-76. PubMed ID: 33458428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.
    Parikh NR; Clark MA; Patel P; Kafka-Peterson K; Zaide L; Ma TM; Steinberg ML; Cao M; Raldow AC; Lamb J; Kishan AU
    Appl Radiat Oncol; 2021 Sep; 10(3):33-40. PubMed ID: 34671700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal Metastasis Abutting Small Bowel: A Novel Magnetic Resonance-Guided Radiation Approach.
    Ghanem AI; Glide-Hurst C; Siddiqui MS; Chetty IJ; Movsas B
    Cureus; 2018 Apr; 10(4):e2412. PubMed ID: 29872593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.